Diagnosis of Esophagogastric Junction Cancer - Retrospective Study
References
- Siewert JR, Stein HJ. Classification of adenocarcinoma of the esophagogastric junction. Br J Surg. 1998;85(11):1457-1459. doi:10.1046/j.1365-2168.1998.00940.x.
- Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med. 2014;371(26):2499-2509. doi:10.1056/NEJMra1314530.
- Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383-2396. doi:10.1016/S0140-6736(17)31462-9.
- Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al. A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127(1):310-330. doi:10.1053/j. gastro.2004.04.010.
- Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825-831.
- Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):872-878.
- Petrescu AM, Alexandrescu D, Constantinoiu S. Chirurgia cancerului de joncțiune esogastrică în România - experiența unei clinici universitare. Chirurgia (Bucur). 2014;109(6):758-765.
- Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw. 2015;13(2):194-227.
- van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074-2084. doi:10.1056/NEJMoa1112088.
- Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007;8(6):545-553. doi:10.1016/S1470-2045(07)70172-9.
- Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232(3):353-361.
- Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11-20.
- Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46-50.
- Ilson DH. Neoadjuvant therapy for esophageal cancer: standard of care in evolution. J Clin Oncol. 2021;39(6):684-694.
- Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol. 2011;8(6):340-347.
- Hegarty JP, Schreiber D, Capanu M, Janjigian YY, Goodman KA, Salo-Mullen EE, et al. National trends in esophagogastric cancer: analysis of the National Cancer Database. Ann Surg Oncol. 2021;28(2):1011-1021.
- Kim Y, Shin A, Gwack J, Jun JK, Oh CM, Choi KS, et al. Comparative epidemiology of esophageal and gastric cancers in Asia vs the West. Cancer Res Treat. 2020;52(3):826-832.
- Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol. 2004;31(4):450-464.
- Saif MW. Management of elderly cancer patients. Cancer Control. 2007;14(1):32-43.
Language: English
Page range: 94 - 100
Published on: Oct 14, 2025
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2025 Dragos Bajan, Stere Popescu, Dimitrie Busu, Vasile Sarbu, Daniel Ovidiu Costea, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution 4.0 License.